Shuttle Pharmaceuticals Stock Investor Sentiment

SHPH Stock  USD 0.42  0.01  2.44%   
Under 53% of Shuttle Pharmaceuticals' traders are presently thinking to get in. The analysis of the overall investor sentiment regarding Shuttle Pharmaceuticals suggests that some traders are interested. Shuttle Pharmaceuticals' investing sentiment shows overall attitude of investors towards Shuttle Pharmaceuticals.
  

Shuttle Pharmaceuticals Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Shuttle Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
few days ago at news.google.com         
12 Health Care Stocks Moving In Mondays Pre-Market Session - Benzinga
Google News at Macroaxis
over a week ago at finance.yahoo.com         
Shuttle Pharma Announces Closing of 5.75 Million Underwritten Offering
Yahoo News
over a week ago at globenewswire.com         
Shuttle Pharma Announces Closing of 5.75 Million Underwritten Offering
Macroaxis News: globenewswire.com
over a week ago at gurufocus.com         
Shuttle Pharma Announces Closing of 5.75 Million Underwritten Offering
Gurufocus Stories at Macroaxis
over a week ago at finance.yahoo.com         
Shuttle Pharma Announces Appointment of Christopher Cooper as Interim Co-CEO to Enhance Business Act...
Yahoo News
over a week ago at gurufocus.com         
Shuttle Pharma Announces Appointment of Christopher Cooper as Interim Co-CEO to Enhance ...
Gurufocus Stories at Macroaxis
over a week ago at finance.yahoo.com         
Shuttle Pharma Announces Pricing of 5.75 Million Underwritten Offering
Yahoo News
over a week ago at globenewswire.com         
Shuttle Pharma Announces Pricing of 5.75 Million Underwritten Offering
Macroaxis News: globenewswire.com
over a week ago at gurufocus.com         
Shuttle Pharma Announces Pricing of 5.75 Million Underwritten Offering
Gurufocus Stories at Macroaxis
over a week ago at news.google.com         
SHPH stock touches 52-week low at 0.5 amid sharp annual decline - Investing.com
Google News at Macroaxis
over two weeks ago at news.google.com         
Amendment SEC Form S-1A filed by Shuttle Pharmaceuticals Holdings Inc. - Quantisnow
Google News at Macroaxis
over two weeks ago at thelincolnianonline.com         
Short Interest in Shuttle Pharmaceuticals Holdings, Inc. Increases By 176.3
news
over two weeks ago at news.google.com         
Shuttle Pharmaceuticals Holdings Enters 2 Million Revolving Loan Agreement -February 28, 2025 at 052...
Google News at Macroaxis
over three weeks ago at seekingalpha.com         
Shuttle Pharmaceuticals reports FY results
seekingalpha News
over three weeks ago at gurufocus.com         
Shuttle Pharma Provides Corporate Update and Reports 2024 Results
Gurufocus Stories at Macroaxis
Far too much social signal, news, headlines, and media speculation about Shuttle Pharmaceuticals that are available to investors today. That information is available publicly through Shuttle media outlets and privately through word of mouth or via Shuttle internal channels. However, regardless of the origin, that massive amount of Shuttle data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Shuttle Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Shuttle Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Shuttle Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Shuttle Pharmaceuticals alpha.

Shuttle Pharmaceuticals Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Shuttle Pharma to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January ...
01/07/2025
2
Shuttle Pharma Reaches Milestone in Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma
01/21/2025
3
Shuttle Pharmaceuticals expands glioblastoma trial By Investing.com - Investing.com Nigeria
01/29/2025
4
Why Five9 Shares Are Trading Higher By Around 13 Here Are 20 Stocks Moving Premarket - Benzinga India
02/21/2025
5
Shuttle Pharmaceuticals Holdings Enters 2 Million Revolving Loan Agreement -February 28, 2025 at 0526 pm EST - Marketscreener.com
02/28/2025
6
SHPH stock touches 52-week low at 0.5 amid sharp annual decline - Investing.com
03/07/2025
7
Shuttle Pharma Announces Pricing of 5.75 Million Underwritten Offering
03/12/2025
8
Shuttle Pharma Announces Closing of 5.75 Million Underwritten Offering
03/13/2025
9
12 Health Care Stocks Moving In Mondays Pre-Market Session - Benzinga
03/17/2025

Complementary Tools for Shuttle Stock analysis

When running Shuttle Pharmaceuticals' price analysis, check to measure Shuttle Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shuttle Pharmaceuticals is operating at the current time. Most of Shuttle Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Shuttle Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shuttle Pharmaceuticals' price. Additionally, you may evaluate how the addition of Shuttle Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Technical Analysis
Check basic technical indicators and analysis based on most latest market data